Peptidomic analysis of the neurolysin-knockout mouse brain

Journal of Proteomics

Volumn 111, Issue , 2014, Pages 238-248

  Castro, Leandro M ^a,b   Cavalcanti, Diogo M L P ^a   Araujo, Christiane B ^a   Rioli, Vanessa ^c   Icimoto, Marcelo Y ^b   Gozzo, Fábio C ^d   Juliano, Maria ^b   Juliano, Luiz ^b   Oliveira, Vitor ^b   Ferro, Emer S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Endopeptidase; Hemopressin; Intracellular peptides; Neurolysin; Oligopeptidase; Peptide metabolism

Indexed keywords

METENKEPHALIN; NEUROLYSIN; OCTAPEPTIDE; RECOMBINANT PROTEIN; ENKEPHALIN; HEMOGLOBIN; HEMOPRESSIN; METALLOPROTEINASE; NEUROPEPTIDE; NEUROTENSIN; OLIGOPEPTIDASE; PEPTIDE; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE; PROENKEPHALIN; PROTEIN PRECURSOR; PROTEINASE; THIMET OLIGOPEPTIDASE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; EMBRYO; IN VITRO STUDY; KNOCKOUT MOUSE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PEPTIDOMICS; PROTEIN DEGRADATION; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; ALLELE; ANIMAL; BRAIN; C57BL MOUSE; CHEMISTRY; GENETICS; GENOTYPE; METABOLISM; PROTEOMICS; TANDEM MASS SPECTROMETRY;

ALLELES; ANIMALS; BRAIN; ENDOPEPTIDASES; ENKEPHALINS; GENOTYPE; HEMOGLOBINS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDES; NEUROTENSIN; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PEPTIDES; PROTEIN PRECURSORS; PROTEOMICS; RECOMBINANT PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84910041718     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.03.043     Document Type: Article

References (58)

1. Dauch P., Vincent J.P., Checler F. Molecular cloning and expression of rat brain endopeptidase 3.4.24.16. J Biol Chem 1995, 270:27266-27271.
2. Checler F., Vincent J.P., Kitabgi P. Purification and characterization of a novel neurotensin-degrading peptidase from rat brain synaptic membranes. J Biol Chem 1986, 261:11274-11281.
3. Barelli H., Vincent J.P., Checler F. Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum. Eur J Biochem 1988, 175:481-489.
4. Barelli H., Vincent J.P., Checler F. Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides. Eur J Biochem 1993, 211:79-90.
5. Vincent B., Vincent J.P., Checler F. Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin. Brain Res 1996, 709:51-58.
6. Mentlein R., Dahms P. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J Neurochem 1994, 62:27-36.
7. Rioli V., Kato A., Portaro F.C., Cury G.K., te Kaat K., Vincent B., et al. Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. Biochem Biophys Res Commun 1998, 250:5-11.
8. Shrimpton C.N., Smith A.I., Lew R.A. Soluble metalloendopeptidases and neuroendocrine signaling. Endocr Rev 2002, 23:647-664.
9. Checler F., Barelli H., Vincent J.P. Tissue distribution of a novel neurotensin-degrading metallopeptidase. An immunological approach using monospecific polyclonal antibodies. Biochem J 1989, 257:549-554.
10. Woulfe J., Checler F., Beaudet A. Light and electron microscopic localization of the neutral metalloendopeptidase EC 3.4.24.16 in the mesencephalon of the rat. Eur J Neurosci 1992, 4:1309-1319.
11. Dauch P., Masuo Y., Vincent J.P., Checler F. Endopeptidase 24-16 in murines: tissue distribution, cerebral regionalization, and ontogeny. J Neurochem 1992, 59:1862-1867.
12. Fontenele-Neto J.D., Massarelli E.E., Gurgel Garrido P.A., Beaudet A., Ferro E.S. Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain. J Comp Neurol 2001, 438:399-410.
13. Massarelli E.E., Casatti C.A., Kato A., Camargo A.C., Bauer J.A., Glucksman M.J., et al. Differential subcellular distribution of neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) in the rat brain. Brain Res 1999, 851:261-265.
14. Vincent B., Beaudet A., Dauch P., Vincent J.P., Checler F. Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes. J Neurosci 1996, 16:5049-5059.
15. Barelli H., Fox-Threlkeld J.E., Dive V., Daniel E.E., Vincent J.P., Checler F. Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum. Br J Pharmacol 1994, 112:127-132.
16. Vincent B., Jiracek J., Noble F., Loog M., Roques B., Dive V., et al. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation. Br J Pharmacol 1997, 121:705-710.
17. Tinoco A.D., Saghatelian A. Investigating endogenous peptides and peptidases using peptidomics. Biochemistry 2011, 50:7447-7461.
18. Lyons P.J., Fricker L.D. Peptidomic approaches to study proteolytic activity. Curr Protoc Protein Sci 2011, 3:1-12. [Chapter 18:Unit18 3].
19. Gelman J.S., Sironi J., Castro L.M., Ferro E.S., Fricker L.D. Peptidomic analysis of human cell lines. J Proteome Res 2011, 10:1583-1592.
20. Berti D.A., Morano C., Russo L.C., Castro L.M., Cunha F.M., Zhang X., et al. Analysis of intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells. J Biol Chem 2009, 284:14105-14116.
21. Gelman J.S., Sironi J., Castro L.M., Ferro E.S., Fricker L.D. Hemopressins and other hemoglobin-derived peptides in mouse brain: comparison between brain, blood, and heart peptidome and regulation in Cpefat/fat mice. J Neurochem 2010, 113:871-880.
22. Fricker L.D. Analysis of mouse brain peptides using mass spectrometry-based peptidomics: implications for novel functions ranging from non-classical neuropeptides to microproteins. Mol Biosyst 2010, 6:1355-1365.
23. Feng Y., Reznik S.E., Fricker L.D. ProSAAS and prohormone convertase 1 are broadly expressed during mouse development. Brain Res Gene Expr Patterns 2002, 1:135-140.
24. Pan H., Che F.Y., Peng B., Steiner D.F., Pintar J.E., Fricker L.D. The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study. J Neurochem 2006, 98:1763-1777.
25. Zhang X., Che F.Y., Berezniuk I., Sonmez K., Toll L., Fricker L.D. Peptidomics of Cpe(fat/fat) mouse brain regions: implications for neuropeptide processing. J Neurochem 2008, 107:1596-1613.
26. Fricker L.D., Gelman J.S., Castro L.M., Gozzo F.C., Ferro E.S. Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides. J Proteome Res 2012, 11:1981-1990.
27. Rioli V., Gozzo F.C., Heimann A.S., Linardi A., Krieger J.E., Shida C.S., et al. Novel natural peptide substrates for endopeptidase 24.15, neurolysin, and angiotensin-converting enzyme. J Biol Chem 2003, 278:8547-8555.
28. Cunha F.M., Berti D.A., Ferreira Z.S., Klitzke C.F., Markus R.P., Ferro E.S. Intracellular peptides as natural regulators of cell signaling. J Biol Chem 2008, 283:24448-24459.
29. Russo L.C., Castro L.M., Gozzo F.C., Ferro E.S. Inhibition of thimet oligopeptidase by siRNA alters specific intracellular peptides and potentiates isoproterenol signal transduction. FEBS Lett 2012, 586:3287-3292.
30. Haynes C.M., Yang Y., Blais S.P., Neubert T.A., Ron D. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell 2010, 37:529-540.
31. Morano C., Zhang X., Fricker L.D. Multiple isotopic labels for quantitative mass spectrometry. Anal Chem 2008, 80:9298-9309.
32. Che F.Y., Fricker L.D. Quantitative peptidomics of mouse pituitary: comparison of different stable isotopic tags. J Mass Spectrom 2005, 40:238-249.
33. Che F.Y., Lim J., Pan H., Biswas R., Fricker L.D. Quantitative neuropeptidomics of microwave-irradiated mouse brain and pituitary. Mol Cell Proteomics 2005, 4:1391-1405.
34. Udenfriend S., Stein S., Bohlen P., Dairman W., Leimgruber W., Weigele M. Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 1972, 178:871-872.
35. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
36. Cavalcanti D.M.L.P., Castro L.M., Rosa Neto J.C., Oliveira V., Forti F.L., Iwai L.K., et al. Neurolysin knockout mice generation and initial phenotype characterization. J Biol Chem 2014, Apr 9. [Epub ahead of print].
37. Xapelli S., Agasse F., Grade S., Bernardino L., Ribeiro F.F., Schitine C.S., et al. Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?. Front Cell Neurosci 2014, 8:59.
38. Bauer M., Chicca A., Tamborrini M., Eisen D., Lerner R., Lutz B., et al. Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem 2012, 287:36944-36967.
39. Gelman J.S., Dasgupta S., Berezniuk I., Fricker L.D. Analysis of peptides secreted from cultured mouse brain tissue. Biochim Biophys Acta 1834, 2013:2408-2417.
40. Gomes I., Dale CS Casten K., Geigner M.A., Gozzo F.C., Ferro E.S., et al. Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J 2010, 12:658-669.
41. Brown C.K., Madauss K., Lian W., Beck M.R., Tolbert W.D., Rodgers D.W. Structure of neurolysin reveals a deep channel that limits substrate access. Proc Natl Acad Sci U S A 2001, 98:3127-3132.
42. Tisljar U., Barrett A.J. A distinct thimet peptidase from rat liver mitochondria. FEBS Lett 1990, 264:84-86.
43. Serizawa A., Dando P.M., Barrett A.J. Characterization of a mitochondrial metallopeptidase reveals neurolysin as a homologue of thimet oligopeptidase. J Biol Chem 1995, 270:2092-2098.
44. Rashid M., Wangler N.J., Yang L., Shah K., Arumugam T.V., Abbruscato T.J., et al. Functional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain. J Neurochem 2014, 129:179-189.
45. Checler F. Experimental stroke: neurolysin back on stage. J Neurochem 2014, 129:1-3.
46. Wangler N.J., Santos K.L., Schadock I., Hagen F.K., Escher E., Bader M., et al. Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site. J Biol Chem 2012, 287:114-122.
47. Gomes I., Grushko J.S., Golebiewska U., Hoogendoorn S., Gupta A., Heimann A.S., et al. Novel endogenous peptide agonists of cannabinoid receptors. FASEB J 2009, 23:3020-3029.
48. Dale C.S., Pagano Rde L., Rioli V., Hyslop S., Giorgi R., Ferro E.S. Antinociceptive action of hemopressin in experimental hyperalgesia. Peptides 2005, 26:431-436.
49. Blais P.A., Cote J., Morin J., Larouche A., Gendron G., Fortier A., et al. Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study. Peptides 2005, 26:1317-1322.
50. Lippton H., Lin B., Gumusel B., Witriol N., Wasserman A., Knight M. Hemopressin, a hemoglobin fragment, dilates the rat systemic vascular bed through release of nitric oxide. Peptides 2006, 27:2284-2288.
51. Dodd G.T., Mancini G., Lutz B., Luckman S.M. The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice. J Neurosci 2010, 30:7369-7376.
52. Heimann A.S., Gomes I., Dale C.S., Pagano R.L., Gupta A., de Souza L.L., et al. Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc Natl Acad Sci U S A 2007, 104:20588-20593.
53. Boehning D., Snyder S.H. Novel neural modulators. Annu Rev Neurosci 2003, 26:105-131.
54. Russo L.C., Asega A.F., Castro L.M., Negraes P.D., Cruz L., Gozzo F.C., et al. Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3 epsilon and calmodulin. Proteomics 2012, 12:2641-2655.
55. Berti D.A., Russo L.C., Castro L.M., Cruz L., Gozzo F.C., Heimann J.C., et al. Identification of intracellular peptides in rat adipose tissue: insights into insulin resistance. Proteomics 2012, 12:2668-2681.
56. Gelman J.S., Sironi J., Berezniuk I., Dasgupta S., Castro L.M., Gozzo F.C., et al. Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomib. PLoS One 2013, 8:e53263.
57. Castro L.M., Berti D.A., Russo L.C., Coelho V., Gozzo F.C., Oliveira V., et al. Similar intracellular peptide profile of TAP1/Beta 2 microglobulin double-knockout mice and C57BL/6 wild-type mice as revealed by peptidomic analysis. AAPS J 2010, 12:608-616.
58. Ferro E.S., Rioli V., Castro L.M., Fricker L.D. Intracellular peptides: from discovery to function. EuPA Open Proteomics 2014, 3:143-151.